
Evercore ISI raised Voya Financial’s price target to $91 from $88 while keeping an Outperform rating, implying modest upside from the current $80.82 share price. The firm trimmed 2Q26 EPS estimates to $2.47 from $2.61 and 2027 EPS to $10.80 from $11.02, citing weaker Retirement segment assumptions, partially offset by higher Employee Benefits expectations and stop-loss optionality. Voya also recently reported Q1 2026 adjusted operating EPS of $2.26 versus $2.06 consensus and revenue of $2.03 billion versus $2.01 billion.
The market is starting to separate VOYA’s earnings power from its headline valuation, but the more important signal is that the rerating is being driven by optionality rather than clean fundamental acceleration. That matters because when a financials name moves on multiple expansion, the next leg is usually determined by capital allocation decisions, not just quarterly beats. If management monetizes a low-growth, capital-intensive business line, the stock can re-rate faster than consensus models imply because investors will capitalize the remaining fee-based earnings at a higher multiple. The second-order effect is that downside is now more about execution risk than macro risk. Retirement spread compression is the weak link: if rates drift lower or credit spreads normalize, the earnings mix becomes less supportive and the market will stop paying for “cheap plus optionality.” On the other hand, continued reserve releases in Employee Benefits can mask underwriting noise for several quarters, which creates a window where reported EPS can look better than underlying durability. The consensus may be underestimating how sensitive VOYA is to a divestiture narrative. A credible sale of medical stop loss would likely do three things at once: reduce earnings volatility, lower capital drag, and force a multiple reset higher across the residual franchise. That means the stock could outperform even if near-term EPS estimates are still drifting down, because the market may prefer cleaner capital returns over incremental operating upside. The contrarian risk is that the stock’s cheapness is partly an illusion if buybacks are being executed at a higher average price while estimates are still moving lower. If the next quarter confirms weaker retirement spread earnings without a visible catalyst on portfolio restructuring, this can revert quickly into a low-multiple value trap. The catalyst window is 1-3 months for another earnings print and any strategic update; beyond that, absent asset sales, the market may stop paying for the story.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment